| 000 | 01250 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513143805.0 | ||
| 264 | 0 | _c19980702 | |
| 008 | 199807s 0 0 eng d | ||
| 022 | _a0512-3054 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aCardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group. _h[electronic resource] |
| 260 |
_bWorld Health Organization technical report series _c1998 |
||
| 300 |
_ai-vii, 1-89 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xchemically induced |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aContraceptives, Oral, Combined _xadverse effects |
| 650 | 0 | 4 |
_aContraceptives, Oral, Hormonal _xadverse effects |
| 650 | 0 | 4 | _aEpidemiologic Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aMyocardial Infarction _xchemically induced |
| 650 | 0 | 4 |
_aProgestins _xadverse effects |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aThromboembolism _xchemically induced |
| 773 | 0 |
_tWorld Health Organization technical report series _gvol. 877 _gp. i-vii, 1-89 |
|
| 999 |
_c9582160 _d9582160 |
||